nature.com

Sitemap

  • Log In
  • Register

News blog

Breaking news from the world of science

Advanced search
  • News & Comment
  • News blog Archive
  • Archive by Tag

Archive by tag | DNA sequencing

15 Nov 2013 | 17:00 BST

Promising sequencing contender Oxford Nanopore and market leader Illumina sever financial ties

Posted by Erika Check Hayden | Categories: Biology & Biotechnology, Technology

Two closely watched genetic sequencing technology firms who had been unhappily affiliated have now divorced. UK-based Oxford Nanopore announced on 15 November that it has raised £56.4 million – mostly by selling the 13.5% of its shares that had been owned by San Diego-based Illumina since 2009.  Read more

Tags:

  • DNA sequencing
  • genetic sequencing
  • genomics
  • Illumina
  • Isaac Ro
  • nanopores
  • Oxford Nanopore
  • sequencing technologies
  • Yaniv Erlich

Article tools

  • Email
  • Share/bookmark

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • Google+
    • LinkedIn
    • Reddit
    • StumbleUpon

06 Dec 2012 | 15:09 BST

Expert tours his own exome, and finds mainly false alarms

Posted by Monya Baker | Categories: Biology & Biotechnology

Expert tours his own exome, and finds mainly false alarms

When 23andMe offered a few select clients the opportunity to have the protein-encoding portion of their genome sequenced, Gabe Rudy jumped at the chance. On Wednesday, he walked strangers through the results. His conclusion: most detected genetic “variants of interest” are either not variants or not interesting. “Clinics beware,” he writes in a blog post detailing the analysis.  Read more

Tags:

  • DNA sequencing
  • genome interpretation

Article tools

  • Email
  • Share/bookmark

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • Google+
    • LinkedIn
    • Reddit
    • StumbleUpon

18 Apr 2012 | 18:03 BST

Roche calls off Illumina takeover effort

Posted by Erika Check | Categories: Biology & Biotechnology, Health and medicine, Industry

Roche has backed off of its hostile takeover bid for Illumina. The move came after Illumina shareholders rebuffed Roche’s efforts to install board members favorable to a merger at the San Diego-based gene sequencing technology company’s 18 April annual meeting.  Read more

Tags:

  • $1000 genome
  • DNA sequencing
  • genomics
  • Illumina
  • Ion Proton
  • Ion Torrent
  • Oxford Nanopore
  • Roche

Article tools

  • Email
  • Share/bookmark

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • Google+
    • LinkedIn
    • Reddit
    • StumbleUpon

04 Apr 2012 | 06:00 BST

DNA has limits, but so does study questioning its value, geneticists say

Posted by Erika Check | Categories: Biology & Biotechnology, Health and medicine, Science communication

Scientists are irked over a paper claiming, as The New York Times reported on Monday, that “DNA’s power to predict illness is limited.” Yes, geneticists have replied; what else is new?  Read more

Tags:

  • DNA sequencing
  • genome sequencing
  • genomics
  • personal genomics

Article tools

  • 7 Comments
  • Email
  • Share/bookmark

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • Google+
    • LinkedIn
    • Reddit
    • StumbleUpon

29 Mar 2012 | 20:01 BST

Geneticists debate what to tell patients about clinical genome sequences

Posted by Erika Check | Categories: Biology & Biotechnology, Health and medicine, Policy

Should patients undergoing genome sequencing be screened for a minimum set of disease-causing mutations, and should adults and children receive different types of genetic results?  Read more

Tags:

  • American College of Genetics and Genomics
  • bioethics
  • DNA sequencing
  • genetics
  • genomics
  • incidental findings
  • Leslie Biesecker
  • return of results
  • Robert Green
  • secondary findings

Article tools

  • Email
  • Share/bookmark

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • Google+
    • LinkedIn
    • Reddit
    • StumbleUpon

07 Feb 2012 | 23:53 BST

Illumina board rejects Roche offer

Posted by Erika Check | Categories: Biology & Biotechnology, Health and medicine, Industry

The board of directors of San Diego-based Illumina today rejected a takeover bid launched by Basel, Switzerland-based Roche. The move by Illumina, which estimates that its machines produce 90 percent of the world’s genetic sequencing output, was not surprising, given the company’s earlier moves to deter the offer.  Read more

Tags:

  • $1000 genome
  • DNA sequencing
  • genomics
  • Illumina
  • Oxford Nanopore
  • Roche

Article tools

  • Email
  • Share/bookmark

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • Google+
    • LinkedIn
    • Reddit
    • StumbleUpon

10 Jan 2012 | 17:57 BST

The $1,000 genome: are we there yet?

Posted by Erika Check | Categories: Biology & Biotechnology, Health and medicine, Technology

The race to the $1000 genome heated up today as Life Technologies announced that it will debut a new sequencing machine this year that will eventually be capable of decoding entire human genomes in a day for less than $1000. The machine, called the Ion Proton, will be the successor to Ion Torrent’s current offering, the Personal Genome Machine (Life Technologies is the parent company of Ion Torrent).  Read more

Tags:

  • DNA sequencing
  • Illumina
  • Ion Proton
  • Ion Torrent
  • Jonathan Rothberg
  • Life Technologies
  • Personal Genome Machine

Article tools

  • Email
  • Share/bookmark

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • Google+
    • LinkedIn
    • Reddit
    • StumbleUpon

About this blog

Archived newsblog. Breaking news from the world of science, brought to you by Nature’s news team.
  • E-alert
  • RSS
  • Facebook
  • Twitter
nature.com blogs home

Recent comments on this blog

  • Any living organism may feel pain as I think. The same is being proved for crabs and lobsters also. This… ... Read more
    -- Hindi Sahitya

    Experiments reveal that crabs and lobsters feel pain

  • In my opinion, if the risks were known before the trial they should have been disclosed. I bet the… ... Read more
    -- Fernando Aleman

    US research ethics agency upholds decision on informed consent

  • Steven – the dispute was covered by a few chemistry magazines in 2004 when Roald Hoffmann published his account. Here… ... Read more
    -- Richard Van Noorden

    Chemistry credit disputes under the spotlight

  • I would like to find out more about the dispute between Robert Woodward and Corey. R B Woodward was… ... Read more
    -- Steven Levine

    Chemistry credit disputes under the spotlight

  • The report produced by the investigators does not say so explicitly, probably out of fear of prejudicing future criminal/civil inquiries,… ... Read more
    -- Junichiro Taketani

    Contamination created controversial ‘acid-induced’ stem cells

Blog Archive

Categories

  • Biology & Biotechnology
  • Books & Arts
  • Chemistry
  • Earth, environment & ecology
  • Energy
  • Health and medicine
  • Industry
  • Lab life
  • Natural disasters
  • Physics & Mathematics
  • Policy
  • Science communication
  • Space and astronomy
  • Technology
  • Uncategorized

Blogs we like

  • Blogroll

    Retraction Watch

  • Blogroll

    Science Insider

  • Blogroll

    Scientific American

  • Blogroll

    Spoonful of Medicine

  • Blogroll

    The Sceptical Chymist

All nature.com blogs

  • A view From the BridgeA view From the Bridge
  • Action PotentialAction Potential
  • Flat Chat Flat Chat
  • Free AssociationFree Association
  • House of WisdomHouse of Wisdom
  • IndigenusIndigenus
  • MethagoraMethagora
  • Nature Future ConditionalNature Future Conditional
  • nature.com blogsnature.com blogs
  • Naturejobs BlogNaturejobs Blog
  • Of Schemes and Memes BlogOf Schemes and Memes Blog
  • On your wavelengthOn your wavelength
  • Plant LifePlant Life
  • Scientific DataScientific Data
  • Soapbox ScienceSoapbox Science
  • Spoonful of MedicineSpoonful of Medicine
  • StepwiseStepwise
  • The Sceptical ChymistThe Sceptical Chymist
  • Trade SecretsTrade Secrets
  • About us
  • Contact us
  • Accessibility statement
  • Help
  • Privacy policy
  • Use of cookies
  • Legal notice
  • Terms
  • Nature jobs
  • Nature Asia
  • Nature Education
  • RSS web feeds
Advanced search

© 2021 Springer Nature Limited. All Rights Reserved. partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER